StockTipsArenaBeta

Eris Lifesciences LimitedShare price targets & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,324.3+2.60 (+0.20%)
Analysts lean BUY·all 5 long-term calls are BUY·consensus 1Y target ₹1,681.4 (27.0% above CMP)
₹1,681.4
27.0% above CMP
₹1,471 – ₹1,800
5 active 1Y targets
7 open
7 BUY · 0 SELL (all horizons)
N/A
8 of 10 closed calls needed
Watch ERIS for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (15) · loading…

BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)
AI5+·1−+1.1% P&L+11.1% upside left
₹1,324.3
CMP
Entry*
₹1,310
Target
₹1,471
ECElara Capital· via ET Now (Live)1w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)
AI5+·1−-7.2% P&L+30.6% upside left
₹1,324.3
CMP
Entry*
₹1,427
Target
₹1,730
HSHDFC Securities· via Economic Times New Stock Recos5w ago
BUYERISEris Lifesciences1 Year
AI5+·1−-7.9% P&L+24.6% upside left
₹1,324.3
CMP
Entry
₹1,438
Target
₹1,650
SJSandeep Jain, Tradeswift· via Zee Business (Live)7w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)
AI4+·1−-2.9% P&L+35.9% upside left
₹1,324.3
CMP
Entry*
₹1,364.4
Target
₹1,800
PLPrabhudas Lilladher· via Institutional / Brokerage Research29w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)
AI5+·1−-6.4% P&L+32.6% upside left
₹1,324.3
CMP
Entry*
₹1,414.4
Target
₹1,756
BCBOB Capital Markets· via Institutional / Brokerage Research29w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+18.35% realised0.0% upside left
Entry*
₹1,470.2
Target
₹1,740
hit 12 Jun 2025, 12:00 am
PLPrabhudas Lilladher· via Institutional / Brokerage Research67w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+4.30% realised0.0% upside left
Entry*
₹1,390.2
Target
₹1,450
hit 6 Feb 2025, 12:00 am
PLPrabhudas Lilladher· via Institutional / Brokerage Research82w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+2.00% realised0.0% upside left
Entry*
₹1,390.2
Target
₹1,418
hit 5 Feb 2025, 9:30 am
BCBOB Capital Markets· via Institutional / Brokerage Research82w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+29.32% realised0.0% upside left
Entry*
₹1,274.35
Target
₹1,648
hit 29 May 2025, 12:05 pm
BCBOB Capital Markets· via Institutional / Brokerage Research97w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+32.20% realised0.0% upside left
Entry*
₹907.7
Target
₹1,200
hit 9 Aug 2024, 12:08 pm
BCBOB Capital Markets· via Institutional / Brokerage Research119w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+25.64% realised0.0% upside left
Entry*
₹875.5
Target
₹1,100
hit 29 Jul 2024, 12:07 pm
PLPrabhudas Lilladher· via Institutional / Brokerage Research132w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI2+·1−-20.27% realisedNA upside left
₹1,375.1
At expiry
Entry*
₹1,724.8
Target
₹1,975
expired 6 Aug 2026, 3:30 pm
PLPrabhudas Lilladher· via Institutional / Brokerage Research56w ago
BUYERISEris Lifesciences1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−+46.11% realisedNA upside left
₹1,279.15
At expiry
Entry*
₹875.5
Target
₹1,609
expired 21 Feb 2025, 3:30 pm
VVentura· via Institutional / Brokerage Research132w ago
BUYERISEris Lifesciences1–3 Months* (horizon not stated by the source; assumed from the target's distance)
AI4+·1−-6.5% P&L+32.1% upside left
₹1,324.3
CMP
Entry*
₹1,416
Target
₹1,750
PLPrabhudas Lilladher· via Economic Times New Stock Recos8w ago
BUYERISEris Lifesciences1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)
AI4+·1−-0.2% P&L+8.0% upside left
₹1,324.3
CMP
SL
₹1,270
Entry*
₹1,327.4
Target
₹1,430
SJSandeep Jain, Tradeswift· via Zee Business (Live)9h ago
StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.